Key result
Preoperative GDF-15 is linked to ~2% higher odds of prolonged ICU stay after off-pump CABG.
Why the study?
Prolonged ICU stay after CABG increases morbidity and costs, and the utility of preoperative GDF-15 levels to predict prolonged ICU stay needed evaluation, particularly in the Indian population where data are limited.
Does preoperative growth differentiation factor-15 (GDF-15) level predict prolonged ICU stay (> 4 days) in patients undergoing off-pump coronary artery bypass grafting?
Cohort (n=85)
No
Does preoperative growth differentiation factor-15 (GDF-15) level predict prolonged ICU stay (> 4 days) in patients undergoing off-pump coronary artery bypass grafting?
Preoperative GDF-15 demonstrates strong discriminatory ability (AUC 0.992) as a prognostic biomarker to identify off-pump CABG patients at risk for prolonged ICU stay (>4 days), potentially aiding resource allocation.
Answers are grounded in this paper and cite their sources.
Preoperative GDF-15 was associated with prolonged ICU stay after off-pump CABG; leaves open whether it improves risk stratification in prospective cohorts.
Prolonged intensive care unit (ICU) stay following coronary artery bypass grafting (CABG) is associated with increased morbidity, higher healthcare costs, and greater resource utilization. Elevated preoperative growth differentiation factor-15 (GDF-15) levels in CABG patients were associated with greater susceptibility to adverse outcomes, supporting its utility as a prognostic marker for the duration of ICU stay and adverse postoperative course. To evaluate the utility of preoperative GDF-15 levels in predicting prolonged ICU stay in CABG patients. This study was a retrospective analysis of prospectively collected data involving 85 patients who underwent off-pump CABG. Participants were stratified into group A (ICU stay ≤ 4 days, n = 31) and group B (ICU stay > 4 days, n = 54). Preoperative GDF-15 was quantified using a sandwich enzyme-linked immunosorbent assay (ELISA), and Spearman correlation, multivariable logistic regression, and receiver operating characteristic (ROC) analyses were performed. Preoperative GDF-15 was markedly elevated in group B compared to group A (720 vs. 220 ng/L; p < 0.001) and demonstrated a strong positive correlation with ICU stay (ρ = 0.691; p < 0.001) and an inverse correlation with ejection fraction (EF) (ρ = − 0.487; p < 0.001). ROC analysis showed excellent discriminatory ability (area under the curve (AUC) = 0.992; cutoff 400.50 ng/L; sensitivity 94%; specificity 98%; p < 0.001). Multivariable logistic regression demonstrated an independent association between GDF-15 and prolonged ICU stay (odds ratio (OR) = 1.017; 95% confidence interval (CI) 1.007–1.027; p < 0.001) after adjusting for blood pressure, EF, age, total cholesterol, and simplified acute physiology score II (SAPS II). Preoperative GDF-15 is significantly associated with prolonged ICU stay in patients undergoing CABG and demonstrates potential predictive utility, particularly in the Indian population where such data are limited. However, these findings remain exploratory and require validation in multicenter cohorts before routine clinical application. Preoperative GDF-15 assessment may aid in identifying high-risk patients, optimizing resource allocation, and facilitating preoperative counseling, particularly in high-volume tertiary care cardiac centers in resource-limited settings.
No takes yet. Share an insight, caveat, or question.
Sridhar et al. (2026) conducted a cohort in Patients undergoing off-pump coronary artery bypass grafting (CABG) (n=85). Elevated preoperative growth differentiation factor-15 (GDF-15) level vs. Lower preoperative GDF-15 level / ICU stay ≤ 4 days was evaluated on Prolonged ICU stay (> 4 days) (OR 1.017, 95% CI 1.007-1.027, p=<0.001). Preoperative GDF-15 independently predicted prolonged ICU stay (>4 days) after off-pump CABG (OR 1.017, 95% CI 1.007-1.027, p<0.001; AUC 0.992 at cutoff 400.50 ng/L).
Synapse has enriched 10 related papers. Consider them for comparative context: